Consumers have testing options beyond the once-a-decade colonoscopy. But some doctors question Cologuard's testing program.

Guardant Health is breaking barriers and hoping to get more people screened through the “Shield” test. In 2024, over 53,000 ...

Colorectal cancer is the second leading cause of cancer-related deaths for males and females. Screening for colorectal cancer ...

A new Galleri blood test detected 75% of cancers without current screening options, with over half found in early stage I or ...

Guardant Health stock has had several attempts at breaking out of a cup base. The company has a blood test to detect colon cancer.

Among nearly 25 million privately insured adults, significant shifts in colorectal cancer (CRC) screening practices were identified after the onset of COVID-19. 1 Between 2017 and 2024, colonoscopy ...

Insurers should stop mailing colorectal cancer screening kits without the involvement of the patients’ physicians. Doctors ...

Thousands in KY go unscreened for colon cancer because they lack access or don't want colonoscopies or stool-based tests, but there's another option.

Guardant's liquid biopsy only requires a few vials of blood. Can it really prevent cancer?

Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with ...

The Kentucky Colon Cancer Screening Program has asked the General Assembly for an increase in state funding from $500,000 per ...

Screening is something that people often put on the back burner, ” Katie Couric tells PEOPLE about the public service announcement with Colorectal Cancer Alliance and Maximum Effort.